Sign up for ProNews
Imatinib mesylate 100mg_Gallary

Tyronib® (Imatinb Mesylate) 100mg ⇒ Product Glimpse

Tyronib® (Imatinb Mesylate) 100mg ⇒ 10 Tab

Tyronib 100MG (IMATINIB) - Generic
TYRONIB® (imatinib mesylate)
Buy Generic Tyronib (Imatinib 100mg) contain Imatinib Mesylate equivalent to 100 mg of Imatinib ...
Imatinib (Tyronib®)
tyronib (imatinib) Tyronib (imatinib), which is known as “tyronib” in the ...
Tyronib (imatinib)

Tyronib® (Imatinb Mesylate) 100mg ⇒ 10X10 Tab

Imatinib Mesylate Tablets. we are engaged in offering a broad range of Imatinib Mesylate Tablet 100
Tyronib 100 mg tablet

Imatinib Mesylate Distributor
Tyronib Tablets (imatinib)
Tyronib (Imatinib Mesylate) - 100mg (10 Tablets)
Tyronib ® Imatinib 100mg tablets

Tyronib® (Imatinb Mesylate) 100mg ⇒ 30 Tabs Bottle

Imatinib Mesylate Tablets (tyronib)
(Imatinib Mesyalate)-Bottle
Tyrnoib (imatinib as mesylate) 100mg, 400mg tablets by Taj Pharma
Tyronib-imatinib bottle
Imatinib mesylate is an orally administered, synthetic tyrosine kinase
Tyronib (imatinib mesylate)100mg bottle

Generic Pack

Imatinb Mesylate 100mg ⇒ 10 Tab

Tyronib (Imatinib Mesylate) - 100mg (10 Tablets)
Tyronib (Imatinib Mesylate) - 100mg (10 Tablets)
imatinib product
Imatinib 100mg
Public summary document for Imatinib mesylate, tablets, 100 mg and 400 mg (base), Tyronib®
TYRONIB® (imatinib mesylate) tablets

Imatinb Mesylate 100mg ⇒ 10x10 Tab

News Burst Hematology and Oncology - Imatinib Tablets
Tyronib 100 mg film-coated tablets
(Imatinib) is used to prevent and stop the growth of cancer cells of some types of myeloid leukemia and gastrointestinal stromal tumors. This medicine helps your body to stop making abnormal cells which cause the tumors to grow.
Imatinib brands
Wholesale Medical Supplies Tyronib - Tyronib (imatinib mesylate) Taj Pharma
Tyronib (Imatinib Mesylate) - 100mg (10 Tablets)

Imatinb Mesylate 100mg ⇒ 30 Tabs Bottle

100 mg imatinib tablets. 400 mg tablets are also available.
(Imatinib Mesylate) 100mg
Prescription Drugs-G - Tyronib - Tyronib 100mg Tablets 1X30 each
Imatinib 100mg - bottle
Prescription Drugs-T - Tyronib - Tyronib imatinib mesylate 100mg Tablets 1X30 each Taj Pharma
Tyronib (imatinib mesylate)100mg - bottle


Tyronib® (Imatinb Mesylate), is a targeted therapy used to treat certain types of Leukaemia and soft tissue sarcoma, it may also be used to treat other types of cancers as part of research trial.

Tyronib® (Imatinib Mesylate) may be used to treat:

  • Chronic myeloid leukaemia (CML)
  • A type of acute lymphoblastic leukaemia (ALL) called Philadelphia chromosome positive (Ph+ ALL)
  • Gastro-intestinal stromal tumours (GISTs)
  • A rare type of soft tissue cancer called dermatofibrosarcoma protuberans (DFSP)
  • Other types of cancers as part of a research trial.

Important Safety Information

  • Pregnancy Category D:Imatinib can cause fetal harm when administered to a pregnant woman. There have been post-market reports of spontaneous abortions and infant congenital anomalies from women who have taken Imatinib.

    There are no adequate and well-controlled studies with Imatinib in pregnant women. Women should be advised not to become pregnant when taking Imatinib. If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus.

  • Nursing Mothers:Imatinib and its active metabolite are excreted into human milk. Based on data from three breastfeeding women taking Imatinib, the milk:plasma ratio is about 0.5 for imatinib and about 0.9 for the active metabolite.

  • Pediatric Use:Imatinib safety and efficacy have been demonstrated in children with newly diagnosed Ph+ chronic phase CML and Ph+ ALL. There are no data in children under 1 year of age.

  • Geriatric Use: In the CML clinical studies, approximately 20% of patients were older than 65 years. In the study of patients with newly diagnosed CML, 6% of patients were older than 65 years. No difference was observed in the safety profile in patients older than 65 years as compared to younger patients, with the exception of a higher frequency of edema. The efficacy of Imatinib was similar in older and younger patients.

Patient Information  
Full Prescribing Information